3.1. Study Participants and Intervention Compliance
gastrointestinal distress, light-headedness
We received 288 respondents to the initial screening survey. Of the participants screened for eligibility, a total of 36 participants met inclusion criteria and were enrolled in the trial. One participant randomized to the CURC group withdrew prior to the study initiation due to scheduling conflicts, and one participant withdrew prior to blood sampling due to fear of phlebotomy. All participants randomized to the CON group received the allocated treatment. However, three participants in the CON group were lost to follow-up. One participant withdrew due to adverse reporting of gastrointestinal distress and light-headedness, one withdrew due to personal conflicts unrelated to the study, and one participant withdrew for undisclosed reasons. Therefore, 31 participants (